Amgen Inc (AMGN)
312.47
-2.25
(-0.71%)
USD |
NASDAQ |
May 17, 16:00
312.53
+0.06
(+0.02%)
After-Hours: 20:00
Amgen Cash and Short Term Investments (Annual): 10.94B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.94B |
| December 31, 2022 | 9.305B |
| December 31, 2021 | 8.037B |
| December 31, 2020 | 10.65B |
| December 31, 2019 | 8.911B |
| December 31, 2018 | 29.30B |
| December 31, 2017 | 41.68B |
| December 31, 2016 | 38.08B |
| December 31, 2015 | 31.38B |
| December 31, 2014 | 27.03B |
| December 31, 2013 | 19.40B |
| December 31, 2012 | 24.06B |
| December 31, 2011 | 20.64B |
| December 31, 2010 | 17.42B |
| December 31, 2009 | 13.44B |
| December 31, 2008 | 9.552B |
| December 31, 2007 | 7.151B |
| December 31, 2006 | 6.277B |
| December 31, 2005 | 5.255B |
| December 31, 2004 | 5.808B |
| December 31, 2003 | 5.123B |
| Date | Value |
|---|---|
| December 31, 2002 | 4.664B |
| December 31, 2001 | 2.662B |
| December 31, 2000 | 2.028B |
| December 31, 1999 | 1.333B |
| December 31, 1998 | 201.10M |
| December 31, 1997 | 239.10M |
| December 31, 1996 | 169.30M |
| December 31, 1995 | 66.70M |
| December 31, 1994 | 211.30M |
| December 31, 1993 | 128.50M |
| December 31, 1992 | 92.00M |
| December 31, 1991 | 146.50M |
| March 31, 1991 | 35.70M |
| March 31, 1990 | 39.20M |
| March 31, 1989 | 20.70M |
| March 31, 1988 | 105.60M |
| March 31, 1987 | 57.60M |
| March 31, 1986 | 66.60M |
| March 31, 1985 | 22.30M |
| March 31, 1984 | 37.60M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
8.037B
Minimum
2021
10.94B
Maximum
2023
9.569B
Average
9.305B
Median
2022
Cash and Short Term Investments (Annual) Benchmarks
| Johnson & Johnson | 22.93B |
| Eli Lilly and Co | 2.928B |
| Merck & Co Inc | 7.093B |
| Vertex Pharmaceuticals Inc | 11.22B |
| Viking Therapeutics Inc | 362.08M |